GE vs LAB · P/E 44, rev $45.85B vs rev $174.4M
GE Aerospace (GE) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported GE revenue for 2025-12-31 was $45.85B. Net income was $8.70B. Revenue was up 324.1% from 2024-12-31 to 2025-12-31. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
GE currently screens at market cap $373.04B and trailing P/E 44.4. LAB currently screens at market cap $317.1M.
Not investment advice. Open the GE and LAB stock pages for the full models.
Not investment advice.